# Study of Co-administration of Olmesartan Medoxomil Plus Amlodipine in Patients With Mild to Severe Hypertension

> **NCT00185133** · PHASE3 · COMPLETED · sponsor: **Daiichi Sankyo** · enrollment: 1900 (—)

## Conditions studied

- Hypertension

## Interventions

- **DRUG:** Olmesartan medoxomil
- **DRUG:** Amlodipine

## Key facts

- **NCT ID:** NCT00185133
- **Lead sponsor:** Daiichi Sankyo
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2005-05
- **Primary completion:** —
- **Final completion:** 2007-01
- **Target enrollment:** 1900 (—)
- **Last updated:** 2018-12-24


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00185133

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00185133, "Study of Co-administration of Olmesartan Medoxomil Plus Amlodipine in Patients With Mild to Severe Hypertension". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT00185133. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*